Na Cocer Peptides
ukwezi gushize
INGINGO ZOSE N'AMAKURU Y’IBICURUZWA BITANZWE KURI URU RUBUGA BISANZWE KUBONA AMAKURU N'INTEGO Z'UBUREZI.
Ibicuruzwa byatanzwe kururu rubuga bigenewe gusa mubushakashatsi bwa vitro. Mu bushakashatsi bwa vitro (Ikilatini: * mu kirahure *, bisobanura mu bikoresho by'ibirahure) bikorwa hanze y'umubiri w'umuntu. Ibicuruzwa ntabwo ari imiti, ntabwo byemejwe n’ikigo cy’Amerika gishinzwe ibiryo n’ibiyobyabwenge (FDA), kandi ntigomba gukoreshwa mu gukumira, kuvura, cyangwa gukiza indwara iyo ari yo yose y’ubuvuzi, indwara, cyangwa indwara. Birabujijwe rwose n'amategeko kwinjiza ibyo bicuruzwa mumubiri wabantu cyangwa inyamaswa muburyo ubwo aribwo bwose.
Umubyibuho ukabije wabaye ikibazo cy’ubuzima rusange ku isi hose, hamwe n’ingaruka nyinshi ku buzima bw’umubiri w’abantu, nko gutera indwara zifata umutima, indwara ya diyabete, n’izindi ndwara zidakira. Mu myaka yashize, ibiyobyabwenge bya GLP-1 byagaragaye nkuburyo bwiza bwo kuvura mubyerekeranye no gucunga umubyibuho ukabije.
![]()
Igishushanyo 1 Uburyo bushoboka bwo kugabanya ibiro byatewe na GLP-1. GI, Gastrointestinal; GLP-1, Glucagon isa na peptide-1; GLP-1R, reseptor ya Glucagon-peptide-1.
Uburyo bwibikorwa byibiyobyabwenge bya GLP-1 mukuvura umubyibuho ukabije
GLP-1 ni peptide ya endogenous isohoka na selile L muri sisitemu yo mu nda. Ibiyobyabwenge bya GLP-1, bizwi kandi nka GLP-1 reseptor agonist (GLP-1 RAs), bigana ingaruka zifatika za GLP-1 ukoresheje reseptor ya GLP-1 hamwe ninzira zayo zerekana inzira, bityo bikagira ingaruka zitandukanye zifasha mukugenzura ibiro.
Guteza imbere gusohora kwa insuline: GLP-1 RAs itera gusohora insuline kuva selile pancreatic β selile muburyo bwa glucose. Iyo urugero rwa glucose rwamaraso ruzamutse, GLP-1 RAs ihuza reseptor ya GLP-1 hejuru yuturemangingo twa pancreatic β, ikora inzira yerekana ibimenyetso byerekana inzira ya insuline no gusohora, bityo bikagabanya urugero rwa glucose yamaraso. Guhagarika amaraso ya glucose bifasha kugabanya ibinure no kubika, kurinda ubushake bwo kurya no kwiyongera ibiro biterwa nihindagurika ryamaraso glucose.
Kurwanya ubushake bwo kurya: GLP-1 RAs ikora kuri sisitemu yo hagati yububiko, cyane cyane uturere twubwonko bujyanye no kurya, nka hypothalamus. Muguhuza reseptor ya GLP-1 hejuru ya neurone ya hypothalamic, bagenga irekurwa rya neuropeptide, nko kugabanya ururenda rwa peptide itera ubushake bwo kurya no kongera imvugo ya peptide itera ubushake bwo kurya, bityo bigatuma umuntu yumva yuzuye, agaburira ibiryo, kandi akagera no kugenzura ibiro.
Gutinda gusiba gastrica: GLP-1 RAs itinda umuvuduko wibintu byigifu byinjira mu mara mato, bikongerera igihe ibiryo biguma munda kandi bigatanga ibitekerezo byuzuye byuzuye. Uku gutinda kwa gastrici ntigabanya gusa ingano yifunguro ahubwo binagabanya urugero rwa glucose yamaraso, birinda umuvuduko wamaraso glucose nyuma yinyuma bityo bikagabanya kwegeranya amavuta.
![]()
Gahunda ya 1 Igishushanyo mbonera cya GLP-1 reseptor agonist: gushyira mu byiciro, umutekano w’ibiyobyabwenge, no gukora neza. GI, Gastrointestinal; GLP-1R, reseptor ya Glucagon isa na peptide-1; PEG, Polyethylene glycol.
Gukoresha imiti ya GLP-1 mu kuvura umubyibuho ukabije
Kuvura umubyibuho ukuze: Mu kuvura umubyibuho ukabije, GLP-1 RAs yageze ku bisubizo bikomeye. Igeragezwa rya Phase III ivuriro rya semaglutide ryarangiye, ibisubizo byerekana ingaruka zikomeye zo kugabanya ibiro. MU NTAMBWE 2.4 mg / icyumweru umushinga wa semaglutide, abarwayi bagize ibiro byinshi, bikomeza kwemeza imikorere ya GLP-1 RAs mukuvura umubyibuho ukabije. Iyi miti isanzwe ikoreshwa nkigice cya gahunda yuzuye yo kugabanya ibiro, ifatanije no kugenzura imirire hamwe nimyitozo ngororamubiri, kugirango bigerweho neza.
Kuvura umubyibuho ukabije mu bwana: Ubushakashatsi buherutse gukorwa bwerekanye ko imiti ya GLP-1 nka exenatide, semaglutide, na liraglutide yakoreshejwe mu kuvura indwara ziterwa n'umubyibuho ukabije mu bwana, nk'umubyibuho ukabije, umubyibuho ukabije ujyanye na syndrome ya polycystic ovary (PCOS), n'umubyibuho ukabije wa hypothalamic. Kurugero, ubushakashatsi bwerekanye ko iyi miti igira ingaruka runaka mukugenzura kwiyongera kwabana mubana, gufasha kunoza ibipimo bya metabolike, no gutanga uburyo bushya bwo kuvura umubyibuho ukabije mubana.
Kuvura umubyibuho ukabije ku bantu badasanzwe - abarwayi ba PCOS: Indwara ya polycystic ovary syndrome (PCOS) ni indwara ikunze kwibasira endocrine mu bagore bafite imyaka yo kubyara, kandi umubyibuho ukabije wiganje mu barwayi ba PCOS. GLP-1 RAs ifite ibyiza byihariye mu kuvura umubyibuho ukabije ku barwayi ba PCOS. Ubushakashatsi bwerekanye ko ubuvuzi bwa GLP-1 butagabanya ibiro gusa ku barwayi ba PCOS ahubwo binateza imbere insuline, bikagabanya hyperandrogenism, ndetse bikongerera amahirwe yo gusama ndetse no gufumbira vitro. Ibi bituma GLP-1 RAs itanga uburyo bwiza bwo kuvura abarwayi bafite PCOS bafite umubyibuho ukabije, bitanga inzira nshya zo kuzamura ubuzima bwabo nuburumbuke.
Umwanzuro
Muri make, ibiyobyabwenge bya GLP-1, nkimbaraga zigaragara mubijyanye no kuvura umubyibuho ukabije, byerekana ibyifuzo byokwifashishwa mu kuvura umubyibuho ukabije ku bantu bakuru, abana, ndetse n’abaturage badasanzwe (nk'abarwayi ba PCOS) kubera uburyo bwabo bwihariye bwo gukora. Binyuze mu nzira nyinshi, zirimo guteza imbere gusohora insuline, guhagarika ubushake bwo kurya, no gutinda gusiba gastric, GLP-1 RAs ifasha abarwayi kugabanya ibiro no kuzamura imiterere ya metabolike.
Mu kuvura umubyibuho ukabije ukuze, imiti nka liraglutide na semaglutide yemejwe hakoreshejwe ibizamini byo kwa muganga, itanga uburyo bwizewe bwo kuvura abarwayi bafite umubyibuho ukabije. Mu kuvura umubyibuho ukabije ku barwayi ba PCOS, GLP-1 RAs ntabwo ifasha kugabanya ibiro gusa ahubwo inanahindura neza indwara ya endocrine ijyanye niyi ndwara, itanga inyungu nyinshi kubarwayi ba PCOS.
Inkomoko
[1] Zhang D, Lu H. GLP-1RA: Ibyiringiro bishya mu kuvura umubyibuho ukabije [J]. Ikinyamakuru cyibinyabuzima nubuvuzi, 2025,13 (2): 465-479. https://cstj.cqvip.com/Qikan/Ingingo/Detail?id=HS727602025002035
[2] Kavarian PN, Mosher TL, Haija MA E. Gukoresha glucagon-isa na peptide 1 reseptor agonist mu kuvura umubyibuho ukabije mu bwana. [J] Igitekerezo cya none mubuvuzi bw'abana, 2024,36 5: 542-546. https://api.semanticscholar.org/CorpusID:272115519
[3] Wang JY, Wang QW, Yang XY, n'abandi. GLP-1 reseptor agonist yo kuvura umubyibuho ukabije: Uruhare nk'uburyo butanga icyizere [J]. Imipaka muri Endocrinology, 2023,14: 1085799.DOI: 10.3389 / fendo.2023.1085799.
[4] Pedrosa MR, Franco DR, Gieremek HW, n'abandi. GLP-1 Agonist yo kuvura umubyibuho ukabije no kwirinda indwara zifata umutima: Ni iki tumaze kugeraho kugeza ubu? [J] Raporo ya Atherosclerose Yubu, 2022,24 (11): 867-884.DOI: 10.1007 / s11883-022-01062-2.
[5] Baranowska-Bik A. Ubuvuzi bw'umubyibuho ukabije ku bagore bafite PCOS ukoresheje igereranya rya GLP-1 - inyungu n'imbibi Endokrynologia Polska, 2022,73 (3): 627-643.DOI: 10.5603 / EP.a2022.0047.